The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789
Chitosan as antimicrobial agent: applications and mode of action.
Rabea, E. I., Badawy, M. E.-T., Stevens, C. V., Smagghe, G., & Steurbaut, W. (2003) · Biomacromolecules · doi:10.1021/bm034130m · Cited by 3,123
Antimicrobial activity of metals: mechanisms, molecular targets and applications
Lemire, J. A., Harrison, J. J., & Turner, R. J. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3028 · Cited by 2,746
Antibacterial properties of nanoparticles
Hajipour, M. J., Fromm, K. M., Akbar Ashkarran, A., Jimenez de Aberasturi, D., Larramendi, I. R. D., Rojo, T., Serpooshan, V., Parak, W. J., & Mahmoudi, M. (2012) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.06.004 · Cited by 2,710
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.010 · Cited by 2,586
Antimicrobial properties of tannins
Scalbert, A. (1991) · Phytochemistry · doi:10.1016/0031-9422(91)83426-l · Cited by 2,321
Antimicrobial activity of the metals and metal oxide nanoparticles
Dizaj, S. M., Lotfipour, F., Barzegar-Jalali, M., Zarrintan, M. H., & Adibkia, K. (2014) · Materials Science and Engineering: C · doi:10.1016/j.msec.2014.08.031 · Cited by 1,725
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
Xie, Y., He, Y., Irwin, P. L., Jin, T., & Shi, X. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.02149-10 · Cited by 1,383
Vatansever, F., de Melo, W. C. M. A., Avci, P., Vecchio, D., Sadasivam, M., Gupta, A., Chandran, R., Karimi, M., Parizotto, N. A., Yin, R., et al. (2013) · FEMS Microbiology Reviews · doi:10.1111/1574-6976.12026 · Cited by 1,127
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity
Venugopala, K. N., Rashmi, V., & Odhav, B. (2013) · BioMed Research International · doi:10.1155/2013/963248 · Cited by 959
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
The Challenge of Antibiotic Resistance
Levy, S. B. (1998) · Scientific American · doi:10.1038/scientificamerican0398-46 · Cited by 867
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli
Cui, Y., Zhao, Y., Tian, Y., Zhang, W., Lü, X., & Jiang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.057 · Cited by 862
The importance of efflux pumps in bacterial antibiotic resistance
Webber, M. A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg050 · Cited by 853
Biofilms: implications in bioremediation
Singh, R., Paul, D., & Jain, R. K. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.07.001 · Cited by 825
Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria
Lara, H. H., Ayala-Núñez, N. V., Ixtepan Turrent, L. D. C., & Rodríguez Padilla, C. (2010) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-009-0211-3 · Cited by 804
Antifungal Activity of Silver Ions and Nanoparticles on Phytopathogenic Fungi
Jo, Y.-K., Kim, B. H., & Jung, G. (2009) · Plant Disease · doi:10.1094/pdis-93-10-1037 · Cited by 772
Knetsch, M. L. W., & Koole, L. H. (2011) · Polymers · doi:10.3390/polym3010340 · Cited by 715
Mechanisms of antimicrobial resistance in bacteria
Tenover, F. C. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.219 · Cited by 637
Emerging Mechanisms of Fluoroquinolone Resistance
Hooper, D. C. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0702.010239 · Cited by 633
Efflux-mediated multiresistance in Gram-negative bacteria
Poole, K. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00763.x · Cited by 613
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Plant-Derived Antimicrobial Compounds: Alternatives to Antibiotics
Savoia, D. (2012) · Future Microbiology · doi:10.2217/fmb.12.68 · Cited by 601
Zhao, Y., Tian, Y., Cui, Y., Liu, W., Ma, W., & Jiang, X. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1028843 · Cited by 592
Mechanisms of bacterial biocide and antibiotic resistance: ANTIBIOTIC AND BIOCIDE RESISTANCE
Poole, K. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.8.x · Cited by 513
Active efflux of bile salts by Escherichia coli
Thanassi, D. G., Cheng, L. W., & Nikaido, H. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2512-2518.1997 · Cited by 471
De novo design of biomimetic antimicrobial polymers
Tew, G. N., Liu, D., Chen, B., Doerksen, R. J., Kaplan, J., Carroll, P. J., Klein, M. L., & DeGrado, W. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082046199 · Cited by 442
Brown, A. N., Smith, K., Samuels, T. A., Lu, J., Obare, S. O., & Scott, M. E. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.06513-11 · Cited by 420
Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles
Hetrick, E. M., Shin, J. H., Paul, H. S., & Schoenfisch, M. H. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.052 · Cited by 406
Antimicrobial Properties of a Novel Silver-Silica Nanocomposite Material
Egger, S., Lehmann, R. P., Height, M. J., Loessner, M. J., & Schuppler, M. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01658-08 · Cited by 406
Van Bambeke, F., Balzi, E., & Tulkens, P. M. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00291-4 · Cited by 404
Bacterial conjugation: a two‐step mechanism for DNA transport
Llosa, M., Gomis‐Rüth, F. X., Coll, M., & Cruz, F. D. L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03014.x · Cited by 400
Antibacterial activities of magnesium oxide (MgO) nanoparticles against foodborne pathogens
Jin, T. Z., & He, Y. (2011) · Journal of Nanoparticle Research · doi:10.1007/s11051-011-0595-5 · Cited by 384
Liposomes as delivery systems for antibiotics
Drulis-Kawa, Z., & Dorotkiewicz-Jach, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.033 · Cited by 356
Role of Biofilms in Antimicrobial Resistance
Donlan, R. M. (2000) · ASAIO Journal · doi:10.1097/00002480-200011000-00037 · Cited by 351
Friedman, A. J., Phan, J., Schairer, D. O., Champer, J., Qin, M., Pirouz, A., Blecher-Paz, K., Oren, A., Liu, P. T., Modlin, R. L., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.399 · Cited by 345
The growing role of nanotechnology in combating infectious disease
Blecher, K., Nasir, A., & Friedman, A. (2011) · Virulence · doi:10.4161/viru.2.5.17035 · Cited by 345
Phylogeny of multidrug transporters
Saier, Jr., & Paulsen, I. T. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0246 · Cited by 333
DeLeo, F. R., Chen, L., Porcella, S. F., Martens, C. A., Kobayashi, S. D., Porter, A. R., Chavda, K. D., Jacobs, M. R., Mathema, B., Olsen, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321364111 · Cited by 329
Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria
Nikaido, H. (2001) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0247 · Cited by 317
Delivery of antibiotics with polymeric particles
Xiong, M.-H., Bao, Y., Yang, X.-Z., Zhu, Y.-H., & Wang, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.002 · Cited by 302
Multiple antibiotic resistance and efflux
Nikaido, H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80083-0 · Cited by 301
The ins and outs of RND efflux pumps in Escherichia coli
Anes, J., McCusker, M. P., Fanning, S., & Martins, M. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00587 · Cited by 293
Low, D. E., Keller, N., Barth, A., & Jones, R. N. (2001) · Clinical Infectious Diseases · doi:10.1086/320185 · Cited by 289
Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin
Chan, M. M.-Y. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00886-3 · Cited by 287
Köhler, T., van Delden, C., Curty, L. K., Hamzehpour, M. M., & Pechere, J.-C. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5213-5222.2001 · Cited by 287
Antimicrobial hydrogels: A new weapon in the arsenal against multidrug-resistant infections
Ng, V. W. L., Chan, J. M. W., Sardon, H., Ono, R. J., García, J. M., Yang, Y. Y., & Hedrick, J. L. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.028 · Cited by 279
Yeast multidrug resistance: The PDR network
Balzi, E., & Goffeau, A. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110333 · Cited by 279
Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy
Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W. V., & Pagès, J.-M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl493 · Cited by 270
The Role of Nanotechnology in Combating Multi-Drug Resistant Bacteria
Singh, R., Smitha, M. S., & Singh, S. P. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.9527 · Cited by 265
Antibiotic Resistance in Streptococcus pneumoniae
Tomasz, A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s85 · Cited by 264
Vancomycin‐Resistant Enterococci: Mechanisms and Clinical Observations
Gold, H. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321815 · Cited by 258
Tuning the Composition of AuPt Bimetallic Nanoparticles for Antibacterial Application
Zhao, Y., Ye, C., Liu, W., Chen, R., & Jiang, X. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401035 · Cited by 249
Piperine, a Phytochemical Potentiator of Ciprofloxacin against Staphylococcus aureus
Khan, I. A., Mirza, Z. M., Kumar, A., Verma, V., & Qazi, G. N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.810-812.2006 · Cited by 248
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli
Nilsson, A. I., Berg, O. G., Aspevall, O., Kahlmeter, G., & Andersson, D. I. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2850-2858.2003 · Cited by 241
Sutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Neidell, M. J., Cohen, B., Furuya, Y., Hill, J., Jeon, C. Y., Glied, S., & Larson, E. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis552 · Cited by 223
Synthetic Mimic of Antimicrobial Peptide with Nonmembrane-Disrupting Antibacterial Properties
Gabriel, G. J., Madkour, A. E., Dabkowski, J. M., Nelson, C. F., Nüsslein, K., & Tew, G. N. (2008) · Biomacromolecules · doi:10.1021/bm800855t · Cited by 222
Upadhyay, A., Upadhyaya, I., Kollanoor-Johny, A., & Venkitanarayanan, K. (2014) · BioMed Research International · doi:10.1155/2014/761741 · Cited by 222
The origins and molecular basis of antibiotic resistance
Hawkey, P. M. (1998) · BMJ · doi:10.1136/bmj.317.7159.657 · Cited by 221
Friedman, A. J., Han, G., Navati, M. S., Chacko, M., Gunther, L., Alfieri, A., & Friedman, J. M. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.04.003 · Cited by 220
Antibiotic Resistance Mechanisms in Bacteria: Biochemical and Genetic Aspects
Kos, B., Džidić, S., & Šušković, J. (2008) · University of Zagreb University Computing Centre (SRCE) · Cited by 199
Block versus Random Amphiphilic Copolymers as Antibacterial Agents
Oda, Y., Kanaoka, S., Sato, T., Aoshima, S., & Kuroda, K. (2011) · Biomacromolecules · doi:10.1021/bm200780r · Cited by 198
Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids
Huang, C.-M., Chen, C.-H., Pornpattananangkul, D., Zhang, L., Chan, M., Hsieh, M.-F., & Zhang, L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.08.076 · Cited by 190
The emergence of clinical resistance to tigecycline
Sun, Y., Cai, Y., Liu, X., Bai, N., Liang, B., & Wang, R. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.005 · Cited by 185
Ceftaroline: A Novel Cephalosporin with Activity against Methicillin-resistant Staphylococcus aureus
Saravolatz, L. D., Stein, G. E., & Johnson, L. B. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir147 · Cited by 173
Huang, L., Dai, T., Xuan, Y., Tegos, G. P., & Hamblin, M. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01803-10 · Cited by 172
In Vitro and In Vivo Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline
Macone, A. B., Caruso, B. K., Leahy, R. G., Donatelli, J., Weir, S., Draper, M. P., Tanaka, S. K., & Levy, S. B. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01242-13 · Cited by 170
Hindi, K. M., Ditto, A. J., Panzner, M. J., Medvetz, D. A., Han, D. S., Hovis, C. E., Hilliard, J. K., Taylor, J. B., Yun, Y. H., Cannon, C. L., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.044 · Cited by 169
Tsao, C. T., Chang, C. H., Lin, Y. Y., Wu, M. F., Wang, J.-L., Han, J. L., & Hsieh, K. H. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.06.002 · Cited by 168
Leid, J. G., Ditto, A. J., Knapp, A., Shah, P. N., Wright, B. D., Blust, R., Christensen, L., Clemons, C. B., Wilber, J. P., Young, G. W., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr408 · Cited by 167
The use of cephalosporins for gonorrhea: the impending problem of resistance
Barry, P. M., & Klausner, J. D. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902731993 · Cited by 161
Engler, A. C., Shukla, A., Puranam, S., Buss, H. G., Jreige, N., & Hammond, P. T. (2011) · Biomacromolecules · doi:10.1021/bm2000583 · Cited by 151
Antimicrobial Properties of a Chitosan Dextran-Based Hydrogel for Surgical Use
Aziz, M. A., Cabral, J. D., Brooks, H. J. L., Moratti, S. C., & Hanton, L. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05463-11 · Cited by 149
Nicolosi, D., Scalia, M., Nicolosi, V. M., & Pignatello, R. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.01.015 · Cited by 145
Predictable and unpredictable evolution of antibiotic resistance
Courvalin, P. M. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01940.x · Cited by 145
Khameneh, B., Iranshahy, M., Ghandadi, M., Atashbeyk, D. G., Bazzaz, B. S. F., & Iranshahi, M. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.920025 · Cited by 143
Self-citationBaroud, M., Dandache, I., Araj, G. F., Wakim, R. H., Kanj, S. S., Kanafani, Z. A., Khairallah, M.-T., Sabra, A., Shehab, M., Dbaibo, G. S., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.08.010 · Cited by 139
Han, G., Martinez, L. R., Mihu, M. R., Friedman, A., Friedman, J. M., & Nosanchuk, J. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007804 · Cited by 135
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Rémy, J., Tow-Keogh, C. A., McConnell, T., D'Alton, J., & DeVito, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks307 · Cited by 123
Masi, M., & Pagès, J. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010022 · Cited by 122
Endimiani, A., Hujer, K. M., Hujer, A. M., Armstrong, E. S., Choudhary, Y., Aggen, J. B., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-09 · Cited by 118
Betts, J. W., & Wareham, D. W. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-172 · Cited by 117
The Glycerol-3-Phosphate Permease GlpT Is the Only Fosfomycin Transporter in Pseudomonas aeruginosa
Castañeda-García, A., Rodríguez-Rojas, A., Guelfo, J. R., & Blázquez, J. (2009) · Journal of Bacteriology · doi:10.1128/jb.00748-09 · Cited by 116
Nanoconjugated vancomycin: new opportunities for the development of anti-VRSA agents
Chakraborty, S. P., Sahu, S. K., Mahapatra, S. K., Santra, S., Bal, M., Roy, S., & Pramanik, P. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/10/105103 · Cited by 113
Giglio, E. D., Cometa, S., Ricci, M. A., Cafagna, D., Savino, A. M., Sabbatini, L., Orciani, M., Ceci, E., Novello, L., Tantillo, G. M., et al. (2010) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.07.030 · Cited by 113
From Multifunctionalized Poly(ethylene imine)s toward Antimicrobial Coatings
Pasquier, N., Keul, H., Heine, E., & Möller, M. (2007) · Biomacromolecules · doi:10.1021/bm070353r · Cited by 101
Broad-Spectrum Antimicrobial Supramolecular Assemblies with Distinctive Size and Shape
Fukushima, K., Tan, J. P. K., Korevaar, P. A., Yang, Y. Y., Pitera, J. W., Nelson, A., Maune, H., Coady, D. J., Frommer, J., Engler, A. C., et al. (2012) · ACS Nano · doi:10.1021/nn3035217 · Cited by 100
The antibiotic R&D pipeline: an update
Jabes, D. L. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.08.002 · Cited by 96
Orme, R. P., Douglas, C. W. I., Rimmer, S., & Webb, M. (2006) · PROTEOMICS · doi:10.1002/pmic.200600193 · Cited by 92
Poulou, A., Voulgari, E., Vrioni, G., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01244-13 · Cited by 78
Cefuroxime axetil loaded solid lipid nanoparticles for enhanced activity against S. aureus biofilm
Singh, B., Vuddanda, P. R., Vijayakumar, M. R., Kumar, V., Saxena, P. S., & Singh, S. K. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.03.046 · Cited by 78
Yang, K., Gitter, B., Rüger, R., Wieland, G. D., Chen, M., Liu, X., Albrecht, V., & Fahr, A. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05100h · Cited by 77
Stubbings, W., Leow, P., Yong, G. C., Goh, F. Q. Y., Körber-Irrgang, B., Kresken, M., Endermann, R., & Labischinski, H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00833-10 · Cited by 71
Cometa, S., Iatta, R., Ricci, M. A., Ferretti, C., & Giglio, E. D. (2013) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911513498960 · Cited by 70
Natural Resins and Bioactive Natural Products thereof as Potential Anitimicrobial Agents
Termentzi, A., Fokialakis, N., & Skaltsounis, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795703807 · Cited by 68
New Perspectives on Innovative Drug Discovery: An Overview
Pan, S. Y., Pan, S. L., Yu, Z., Ma, D., Chen, S., Fong, W. F., Han, Y., & Ko, K. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j39w2g · Cited by 65
Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge
Riley, M. A., Robinson, S. M., Roy, C. M., Dennis, M., Liu, V., & Dorit, R. L. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120179 · Cited by 56
Buffet-Bataillon, S., Le Jeune, A., Le Gall-David, S., Bonnaure-Mallet, M., & Jolivet-Gougeon, A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks321 · Cited by 51
Akiyama, T., & Khan, A. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr414 · Cited by 47
Hagihara, M., Crandon, J. L., & Nicolau, D. P. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.632631 · Cited by 46
Bouza, E., & Burillo, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.06.048 · Cited by 46
Skin Delivery Aspects of Benzoyl Peroxide-Loaded Solid Lipid Nanoparticles for Acne Treatment
Pokharkar, V., Mendiratta, C., Kyadarkunte, A., Bhosale, S. H., & Barhate, G. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.31 · Cited by 45
New agents in development for the treatment of bacterial infections
Abbanat, D., Morrow, B. J., & Bush, K. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.001 · Cited by 42
Ahmed, K., Muiruri, P. W., Jones, G. H., Scott, M. J., & Jones, M. N. (2001) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/s0927-7757(01)00817-2 · Cited by 41
Piddock, L. J. V., Walters, R. N., Jin, Y.-T., et al. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.2.177 · Cited by 41
Zhang, J., Markiewicz, M. J., Mowery, B. P., Weisblum, B., Stahl, S. S., & Gellman, S. H. (2011) · Biomacromolecules · doi:10.1021/bm2013058 · Cited by 40
Tedizolid: A Novel Oxazolidinone for Gram-Positive Infections
Moellering, R. C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit658 · Cited by 40
Mechanisms of Resistance to Antibacterial Agents
Rice, L. B., & Bonomo, R. A. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch66 · Cited by 39
The effect of nanoliposomal formulations onStaphylococcus epidermidisbiofilm
Moghadas-Sharif, N., Bazzaz, B. S. F., Khameneh, B., & Malaekeh‐Nikouei, B. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2013.877483 · Cited by 39
Self-citationTelavancin: A novel lipoglycopeptide antibiotic
Damodaran, S. E., & Madhan, S. (2011) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.81918 · Cited by 33
Application of pH-sensitive fusogenic polymer-modified liposomes for development of mucosal vaccines
Watarai, S., Iwase, T., Tajima, T., Yuba, E., Kono, K., & Sekiya, Y. (2013) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2013.05.005 · Cited by 29
Keelan, J. A., Kemp, M. W., Payne, M. S., Johnson, D. B., Stock, S. J., Saito, M., FERNANDES, P. B., & Newnham, J. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01743-13 · Cited by 26
Novel pharmaceutical molecules against emerging resistant gram-positive cocci
Manfredi, R., & Sabbatani, S. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70020-9 · Cited by 24
Homhuan, A., Kogure, K., Akaza, H., Futaki, S., Naka, T., Fujita, Y., Yano, I., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.017 · Cited by 23
Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa
Jalal, S., Wretlind, G., Gotoh, N., & Wretlind, B. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01516.x · Cited by 23
Efflux systems in Serratia marcescens
Mardanova, A. M., Bogomolnaya, L. M., Романова, Ю. Д., & Sharipova, M. R. (2013) · Microbiology · doi:10.1134/s0026261714010093 · Cited by 10
Biofilms: The Microbial Castle of Resistance
Abbas, H. A., Serry, F. M. E., & EL-Masry, E. M. (2013) · Research Journal of Pharmacy and Technology · Cited by 10
Mechanisms of Resistance to Antibacterial Agents
Bradford, P. A., & Castanheira, M. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0072 · Cited by 1
Cited by
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Antimicrobial Resistance: A Growing Serious Threat for Global Public Health
Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. (2023) · Healthcare · doi:10.3390/healthcare11131946 · Cited by 2,338
Frieri, M., Kumar, K., & Boutin, A. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.08.007 · Cited by 1,100
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Self-citationAntimicrobial resistance, mechanisms and its clinical significance
Abushaheen, M. A., Muzaheed, Fatani, A. J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., et al. (2020) · Disease-a-Month · doi:10.1016/j.disamonth.2020.100971 · Cited by 511
Metadata
- Authors
- Khameneh, B., Diab, R., Ghazvini, K., & Fazly Bazzaz, B. S.
- Venue
- Microbial Pathogenesis
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 95
- Pages
- 32-42
- ISSN
- 0882-4010 (ISSN-L)
- OpenAlex
- W2274251352
- Cited by
- 345
- References
- 127
- FWCI
- 10.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.